DeMuth Peter has filed 10 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 41600 shares of Elicio Therapeutics, Inc. ($ELTX) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | A | Stock Option (Right to Buy) | 41600 | $0.00 | 41,600.0000 | 17,489,516 | 9999.99% | 0.24% |
| Feb. 2, 2026 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | A | Common Stock | 20800 | $0.00 | 21,543.0000 | 17,489,516 | 2799.46% | 0.12% |
| Dec. 9, 2025 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | M | Common Stock | 362 | $4.41 | 743.0000 | 17,489,516 | 95.01% | 0.00% |
| Dec. 9, 2025 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | M | Stock Option (Right to Buy) | 362 | $0.00 | 0.0000 | 17,489,516 | 100.00% | 0.00% |
| Feb. 3, 2025 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | A | Stock Option (Right to Buy) | 44400 | $0.00 | 44,400.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | M | Stock Option (Right to Buy) | 381 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 16, 2024 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | M | Common Stock | 381 | $4.41 | 381.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | A | Stock Option (Right to Buy) | 29800 | $0.00 | 29,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | A | Stock Option (right to buy) | 342 | $0.00 | 342.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Elicio Therapeutics, Inc. | $ELTX | DeMuth Peter | Chief Scientific Officer | A | Stock Option (right to buy) | 29800 | $0.00 | 29,800.0000 | 0 | 9999.99% | 0.00% |